ArticleSignal transduction and targeted therapy2022

Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40/OX40L-mediated interaction with Th17 cells.

Rui Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.